000 | 01197 a2200337 4500 | ||
---|---|---|---|
005 | 20250513132950.0 | ||
264 | 0 | _c19980305 | |
008 | 199803s 0 0 eng d | ||
022 | _a1040-8401 | ||
024 | 7 |
_a10.1615/critrevimmunol.v18.i1-2.120 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalgaller, M L | |
245 | 0 | 0 |
_aDendritic cell-based immunotherapy of prostate cancer. _h[electronic resource] |
260 |
_bCritical reviews in immunology _c1998 |
||
300 |
_a109-19 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aDendritic Cells _xcytology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstate-Specific Antigen _ximmunology |
650 | 0 | 4 |
_aProstatic Neoplasms _xtherapy |
700 | 1 | _aTjoa, B A | |
700 | 1 | _aLodge, P A | |
700 | 1 | _aRagde, H | |
700 | 1 | _aKenny, G | |
700 | 1 | _aBoynton, A | |
700 | 1 | _aMurphy, G P | |
773 | 0 |
_tCritical reviews in immunology _gvol. 18 _gno. 1-2 _gp. 109-19 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1615/critrevimmunol.v18.i1-2.120 _zAvailable from publisher's website |
999 |
_c9389025 _d9389025 |